Diabetes: Dapagliflozin: An insulin-independent, therapeutic option for type 2 diabetes mellitus

被引：2
|
作者：
Wilson C.
机构：
来源：
Nature Reviews Endocrinology | 2010年 / 6卷 / 10期
关键词：
D O I：
10.1038/nrendo.2010.134
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：531 / 531
相关论文
共 50 条
  • [31] Dapagliflozin and Insulin Resistance in Patients with Type 2 Diabetes
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A304 - A305
  • [32] Evaluation of glucose utilization in patients with insulin-independent diabetes mellitus by using breathing test
    Zyakun, AM
    Mayevsky, EI
    Sokolov, EI
    Starkova, NT
    Davydov, AL
    Grishina, EV
    Kudryavtseva, AI
    Zakharchenko, VN
    Peshenko, VP
    Shidlowsky, M
    BIOFIZIKA, 2004, 49 (05): : 948 - 957
  • [33] Insulin-independent diabetes mellitus. Current aspects of its morphology, etiology, and pathogenesis
    Kloppel, G
    Clemens, A
    PATHOLOGE, 1996, 17 (04): : 269 - 275
  • [34] CELL COMPOSITION OF PANCREATIC-ISLETS IN INSULIN-INDEPENDENT FORMS OF DIABETES-MELLITUS
    AGEEV, AK
    KLINICHESKAYA MEDITSINA, 1984, 62 (08): : 93 - 98
  • [35] LIPID AND APOLIPOPROTEIN PROFILES OF PATIENTS WITH INSULIN-INDEPENDENT DIABETES
    ALAUPOVIC, P
    KNIGHT, C
    LEE, ET
    WEST, KM
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1228 - 1228
  • [36] PYY, a Therapeutic Option for Type 2 Diabetes?
    Guida, Claudia
    Ramracheya, Reshma
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2020, 13
  • [37] Dapagliflozin A Review of its Use in Type 2 Diabetes Mellitus
    Plosker, Greg L.
    DRUGS, 2012, 72 (17) : 2289 - 2312
  • [38] SAFETY OF DAPAGLIFLOZIN IN CLINICAL TRIALS FOR TYPE 2 DIABETES MELLITUS
    Ptaszynska, Agata
    Johnsson, Kristina
    Apanovitch, Anne Marie
    Sugg, Jennifer
    Parikh, Shamik
    List, James
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 50 - 50
  • [39] Safety of dapagliflozin in clinical trials for type 2 diabetes mellitus
    Johnsson, K.
    Ptaszynska, A.
    Apanovitch, A.
    Sugg, J. E.
    Parikh, S. J.
    List, J. F.
    DIABETOLOGIA, 2012, 55 : S304 - S304
  • [40] Dapagliflozin: A guide to its use in type 2 diabetes mellitus
    Hines M.
    Lyseng-Williamson K.A.
    Plosker G.L.
    Drugs & Therapy Perspectives, 2013, 29 (7) : 194 - 199
12345